None listed
Conditions
Brief summary
To measure the impact of point of care testing for lipids (TC/HDL) and diabetes (HbA1c) on the frequency of completed cardiovascular disease (CVD) risk assessments in the eligible population in primary care practices in Northland region, New Zealand
Interventions
Intervention study. 10 GP practices using the cobas b101 POC device to test HbA1c and Cholesterol levels in eligible patients in order to complete CVD risk assessment records. A GP or practice nurse at each center will administer the test using standard diagnostic cartridges and a blood sample obtained by pin prick. The number of completed and non-completed cardiovascular risk profiles of primary health patients achieved using point of care testing over a 12 month period will be compared betwe
Intervention study. 10 GP practices using the cobas b101 POC device to test HbA1c and Cholesterol levels in eligible patients in order to complete CVD risk assessment records. A GP or practice nurse at each center will administer the test using standard diagnostic cartridges and a blood sample obtained by pin prick. The number of completed and non-completed cardiovascular risk profiles of primary health patients achieved using point of care testing over a 12 month period will be compared between the two groups.
Sponsors
University of Auckland
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
35 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
Male or female are aged at least 35 years and less than 80 years old, and meet New Zealand national age, gender and ethnicity guideline criteria for CVD risk assessment and repeat assessment
Exclusion criteria
- are under 35 years old - are 80 years old or older - are not eligible for CVD risk assessment
Outcome results
None listed